These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 6325491
21. In vitro antifungal susceptibility of Candida spp. isolates from patients with chronic periodontitis and from control patients. Ito CY, de Paiva Martins CA, Loberto JC, dos Santos SS, Jorge AO. Braz Oral Res; 2004; 18(1):80-4. PubMed ID: 15273792 [Abstract] [Full Text] [Related]
22. In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species. Yangco BG, Okafor JI, TeStrake D. Antimicrob Agents Chemother; 1984 Apr; 25(4):413-6. PubMed ID: 6329078 [Abstract] [Full Text] [Related]
23. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine]. Mary C, Goudard M, Blancard A, Quilici M, Regli P. Ann Biol Clin (Paris); 1989 Apr; 47(9):546-9. PubMed ID: 2558599 [Abstract] [Full Text] [Related]
24. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Quindós G, Carrillo-Muñoz AJ, Arévalo MP, Salgado J, Alonso-Vargas R, Rodrigo JM, Ruesga MT, Valverde A, Pemán J, Cantón E, Martín-Mazuelos E, Pontón J. Chemotherapy; 2000 Apr; 46(6):395-401. PubMed ID: 11053905 [Abstract] [Full Text] [Related]
26. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients. Moody MR, Young VM, Morris MJ, Schimpff SC. Antimicrob Agents Chemother; 1980 May; 17(5):871-5. PubMed ID: 6249197 [Abstract] [Full Text] [Related]
29. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system. Ellis NS, Bartlett MS, Smith JW. Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827 [Abstract] [Full Text] [Related]
33. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents. Favel A, Michel-Nguyen A, Datry A, Challier S, Leclerc F, Chastin C, Fallague K, Regli P. J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064 [Abstract] [Full Text] [Related]
34. In vitro studies with combinations of 5-fluorocytosine and amphotericin B. Shadomy S, Wagner G, Espinel-Ingroff E, Davis BA. Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814 [Abstract] [Full Text] [Related]
35. Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC. Fromtling RA, Abruzzo GK, Bulmer GS. Mycopathologia; 1986 Apr; 94(1):27-30. PubMed ID: 3014339 [Abstract] [Full Text] [Related]
36. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona]. Torres-Rodríguez JM, Sabaté M, Gallach C, Carrillo A, Madrenys N. Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147 [Abstract] [Full Text] [Related]
39. Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole. Eng RH, Person A, Mangura C, Chmel H, Corrado M. Antimicrob Agents Chemother; 1981 Nov; 20(5):688-90. PubMed ID: 6275783 [Abstract] [Full Text] [Related]